QuiVad

Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on August 11, 2026.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 8.43% on August 19, 2021. The shaded band is the year shown above.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
GSA Capital Partners LLP1.30%newAugust 11, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

History of disclosures

437 disclosures on record for this share.
DateFund% of capitalEnd of publication
March 22, 2022Arrowstreet Capital Limited Partnership0.00%still open
March 18, 2022Millennium International Management LP0.00%still open
March 16, 2022Millennium International Management LP0.70%still open
March 15, 2022Voleon Capital Management LP1.41%still open
March 10, 2022Millennium International Management LP0.60%still open
March 8, 2022PDT Partners LLC0.00%still open
March 7, 2022PDT Partners LLC0.58%still open
March 7, 2022Millennium International Management LP0.50%still open
March 4, 2022PDT Partners LLC0.66%still open
March 4, 2022Millennium International Management LP0.00%still open
March 3, 2022Millennium International Management LP0.52%still open
March 1, 2022Millennium International Management LP0.67%still open
February 25, 2022Millennium International Management LP0.77%still open
February 23, 2022Millennium International Management LP0.81%still open
February 21, 2022GSA Capital Partners LLP1.60%still open
February 21, 2022Millennium International Management LP0.75%still open
February 8, 2022GSA Capital Partners LLP1.56%still open
February 1, 2022GSA Capital Partners LLP1.40%still open
January 28, 2022GSA Capital Partners LLP1.30%still open
January 25, 2022GSA Capital Partners LLP1.27%still open
January 25, 2022Arrowstreet Capital Limited Partnership0.59%still open
January 20, 2022GSA Capital Partners LLP1.15%still open
January 19, 2022Voleon Capital Management LP1.07%still open
January 19, 2022GSA Capital Partners LLP1.00%still open
January 18, 2022Voleon Capital Management LP0.97%still open
January 17, 2022GSA Capital Partners LLP0.82%still open
January 17, 2022PDT Partners LLC0.75%still open
January 14, 2022Voleon Capital Management LP0.89%still open
January 11, 2022Voleon Capital Management LP0.99%still open
January 11, 2022PDT Partners LLC0.82%still open
December 21, 2021Arrowstreet Capital Limited Partnership0.88%still open
December 16, 2021Worldquant LLC0.00%still open
December 10, 2021GSA Capital Partners LLP0.71%still open
December 8, 2021Worldquant LLC0.50%still open
December 7, 2021Worldquant LLC0.00%still open
December 3, 2021GSA Capital Partners LLP0.63%still open
December 2, 2021Worldquant LLC0.53%still open
November 30, 2021Millennium International Management LP0.55%still open
November 29, 2021Millennium International Management LP1.65%still open
November 29, 2021GSA Capital Partners LLP0.58%still open
November 26, 2021Millennium International Management LP1.52%still open
November 25, 2021Millennium International Management LP1.38%still open
November 25, 2021Worldquant LLC0.00%still open
November 24, 2021Voleon Capital Management LP1.04%still open
November 24, 2021Worldquant LLC0.57%still open
November 23, 2021Millennium International Management LP1.24%still open
November 23, 2021Voleon Capital Management LP0.63%still open
November 22, 2021Worldquant LLC0.82%still open
November 19, 2021Millennium International Management LP1.11%still open
November 18, 2021Worldquant LLC0.59%still open

Other companies sold short in Sweden

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/oncopeptides-ab?page=4